- Q1 2024 Photocure ASA Earnings Call TranscriptMay 15, 2024$5.95Earnings
- Q4 2023 Photocure ASA Earnings Call TranscriptFeb 21, 2024$6.5Earnings
- Q3 2023 Photocure ASA Earnings Call TranscriptNov 08, 2023$5Earnings
- Q2 2023 Photocure ASA Earnings Call TranscriptAug 09, 2023$4.75Earnings
- Q1 2023 Photocure ASA Earnings Call TranscriptMay 10, 2023$10.85Earnings
- Q4 2022 Photocure ASA Earnings Call TranscriptFeb 23, 2023$10.85Earnings
- Q3 2022 Photocure ASA Earnings Call TranscriptNov 02, 2022$10.13Earnings
- Q2 2022 Photocure ASA Earnings Presentation TranscriptAug 10, 2022
- Q1 2022 Photocure ASA Earnings Presentation TranscriptMay 11, 2022
- Photocure ASA at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Q4 2021 Photocure ASA Earnings Presentation TranscriptFeb 23, 2022
- Q3 2021 Photocure ASA Earnings Call TranscriptNov 17, 2021$12.25Earnings
- Q2 2021 Photocure ASA Earnings Call TranscriptAug 11, 2021$15.87Earnings
- Photocure ASA Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Photocure ASA Earnings Presentation TranscriptMay 19, 2021
- Q4 2020 Photocure ASA Earnings Call TranscriptMar 03, 2021$14Earnings
- Q3 2020 Photocure ASA Earnings Call TranscriptNov 10, 2020$8.01Earnings
- Q2 2020 Photocure ASA Earnings Call TranscriptAug 18, 2020$7.15Earnings
- Photocure ASA Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Photocure ASA Earnings Call TranscriptMay 07, 2020$6.8Earnings
- Q4 2019 Photocure ASA Earnings Call TranscriptFeb 27, 2020$9.75Earnings
- Q3 2019 Photocure ASA Earnings Call TranscriptNov 07, 2019$6.35Earnings
- Q2 2019 Photocure ASA Earnings Call TranscriptAug 07, 2019$6.5Earnings
- Q1 2019 Photocure ASA Earnings Call TranscriptMay 14, 2019$4.85Earnings
Q4 2023 Photocure ASA Earnings Call Transcript
Good afternoon and good morning, depending on where you are on the globe. This is Dan Schneider, President, and CEO of Photocure. Today we're presenting the Photocure fourth quarter 2023 results. With me today is Erik Dahl, CFO, and David Moskowitz, Vice President of Investor Relations.
Next slide, please. Just a reminder, the normal usual disclaimers are in place for today's presentation. Next slide, please. So fourth quarter highlights for 2023, we continue to see growth and execution on key initiatives despite flexible blue light cystoscopy being discontinued worldwide by Karl Storzâs.
Product revenue grew at 20%, unit sales 4% year-over-year. From a new tower installation standpoint, there were 10 new ones opened in the fourth quarter, seven upgrades. We had 51 Saphira towers placed in 2023. This is the largest installation of rigid towers in any year since the launch of Blue Light Cystoscopy into the US.
We're executing on our plan in Europe. There were over 146 image quality upgrades. What this means is that the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)